AlpInvest leads €600m GP-led on specialty pharma asset
Swiss GP Gyrus Capital originally invested in Essential Pharma in 2019 as part of a family/founder succession plan process.
Swiss GP Gyrus Capital originally invested in Essential Pharma in 2019 as part of a family/founder succession plan process.
Copyright PEI Media
Not for publication, email or dissemination